Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Stalevo 150/37.5/200mg


Contraindicated
Lack of data in pregnant women

Contraindicated
Safety has not been established
Stalevo 150/37.5/200mg :
Type Medicine Withdrawn
Originator B
Agent Abela Freres
Distributor Abela Freres
Laboratory Novartis
Responsible Party Novartis Pharma AG
Origin Switzerland
Manufacturer Orion Corporation
Origin Finland
ATC N04BA03
Revision Date 01/02/2013

Your comment will appear shortly after approval

Stalevo 150/37.5/200mg :

Revision Date : 14/01/2013


Effect Frequency
Abdominal discomfort Common
Abdominal pain Common
Abnormal dreams Common
Agitation Uncommon
Anaemia Common
Angina pectoris Common
Angioedema (Angioneurotic oedema) (Quincke oedema) Rare
Anxiety Common
Arthralgia (Pain joint) (Joint ache) Common
Asthenia Common
Binge eating Not known
Bradykinesia Common
Chest pain Common
Chromaturia Very Common
Colitis Uncommon
Compulsive eating Not known
Compulsive shopping Not known
Confusional state Common
Connective tissue disorder Very Common
Constipation Common
Decreased appetite Common
Dementia Common
Depression Common
Diarrhoea (Diarrhea) Very Common
Dizziness Common
Dry mouth (Xerostomia) Common
Dyskinesia Very Common
Dyspepsia Common
Dysphagia Uncommon
Dyspnoea (dyspnea) Common
Dystonia Common
Fall Common
Fatigue Common
Gait disturbance Common
Gastroduodenal haemorrhage Uncommon
Hair colour changes Uncommon
Hallucination Common
Headache Common
Heart rate increased Common
Hepatitis cholestatic Not known
Hyperhidrosis Common
Hypersexuality Not known
Hypertension Common
Insomnia Common
Libido increased Not known
Liver function test abnormal Uncommon
Malaise Uncommon
Memory impairment Common
Mental impairment Common
Muscle spasms Common
Musculoskeletal pain Very Common
Myalgia Very Common
Myocardial infarction Uncommon
Myocardial ischaemia Common
Nail discolouration Uncommon
Nausea Very Common
Neuroleptic malignant syndrome Not known
Nightmares Common
Oedema peripheral Common
On and off phenomenon Common
Orthostatic hypotension Common
Parkinsonism Common
Pathological gambling Not known
Psychotic disorders Uncommon
Rhabdomyolysis Not known
Seizures Not known
Skin discolouration (Dyschromia) Uncommon
Skin rash Common
Somnolence Common
Sudden onset of sleep Not known
Suicidal behaviour Not known
Sweat discolouration Uncommon
Thrombocytopenia (Thrombopenia) Uncommon
Tremor Common
Urinary retention Uncommon
Urinary tract infection Common
Urticaria Not known
Vision blurred Common
Vomiting Common
Weight decreased (Weight loss) Common
Withdrawal syndrome Not known

Different Units By MoH Code

Revision Date : 08/02/2022

Revision Date : 08/02/2022

Stalevo 150/37.5/200mg  MoH 4010 :
Form Tablet, Film-Coated
Package Size Box of 100
Strength 37.5/200/150mg
Stratum N/A
NSSF ✘
Quarantine ✘
Reg. Number 195484/04
Submission date 01/01/2004
Registration Year 2004
Withdrawn Date 04/05/2021


Price Comparison

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info